GB824461A - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB824461A
GB824461A GB27443/57A GB2744357A GB824461A GB 824461 A GB824461 A GB 824461A GB 27443/57 A GB27443/57 A GB 27443/57A GB 2744357 A GB2744357 A GB 2744357A GB 824461 A GB824461 A GB 824461A
Authority
GB
United Kingdom
Prior art keywords
sulpha
acid addition
addition salt
therapeutic composition
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27443/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Laboratories Inc
Original Assignee
Bristol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Laboratories Inc filed Critical Bristol Laboratories Inc
Publication of GB824461A publication Critical patent/GB824461A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An oral preparation for treating urinary tract infections comprises tetracycline or a non-toxic metal or acid addition salt thereof together with 2,6 - diamino - 3 - phenylazopyridine or a non-toxic acid addition salt thereof and a sulpha drug. The sulpha drug may be sulpha-diazine, -merazine, -methazine, -dimethine, -pyridine, - thiazole, - acetamide, - methylthiadiazole, -isoxazole. The preparation may be in the form of tablets, capsules and liquid suspensions.
GB27443/57A 1956-09-04 1957-08-30 Therapeutic composition Expired GB824461A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US824461XA 1956-09-04 1956-09-04

Publications (1)

Publication Number Publication Date
GB824461A true GB824461A (en) 1959-12-02

Family

ID=22171273

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27443/57A Expired GB824461A (en) 1956-09-04 1957-08-30 Therapeutic composition

Country Status (1)

Country Link
GB (1) GB824461A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212394A (en) * 1987-11-19 1989-07-26 Peter Hand Gb Limited Synergistic antibiotic composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212394A (en) * 1987-11-19 1989-07-26 Peter Hand Gb Limited Synergistic antibiotic composition

Similar Documents

Publication Publication Date Title
AU461619B2 (en) 2, 4, 6-triiodobenzoic acid, compositions for use asx-ray contrast agent and process for their production thereof
GB824461A (en) Therapeutic composition
PT64980A (en) Process for preparing carboxylic acid amides with hypolipaemic effect,application of the same for preparing pharmaceutical compositions with hypolipaemic effect and application of said pharmaceutical compositions for the treatment of hyperlipaemia
GR61158B (en) N-tetrahydrofurfuryl-noroxymorphone,salts thereof by addition of acid,pharmaceutical mediums containing them and process for the preparation thereof
ZA708711B (en) 2-acylamino-1,3,4-thiadiazole(thi)ones-(5),process for their preparation and their use as herbicides
FR1323056A (en) Method and composition for coating pharmaceutical tablets
ES447712A1 (en) Pharmaceutical suspension for opaqing empty gelatin capsules
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.
GB992956A (en) Pharmaceutical preparations containing pyrrolidone carboxylic acid and salts and esters thereof
FI47485C (en) A process for the preparation of indole-substituted amides suitable for therapeutic purposes of lysergic acid or 9,10-dihydrolysergic acid.
GB1045969A (en) Sodium betaine aspartate
GB1269616A (en) Improvements in pharmaceutical compositions
HUP9903839A3 (en) Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence
GB1194912A (en) Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin
ES211981U (en) Jewelery pendant. (Machine-translation by Google Translate, not legally binding)
CA503996A (en) Pharmaceutical composition for use in the treatment of keratin
GB880445A (en) Improvements relating to the heat treatment of material
BE554777A (en) PROCESS FOR THE PREPARATION OF N-ALCOYL-ALCOYL-PIPERIDINE-MONOCARBOXYL ACID AMIDS AND N-ALCOYL-ALCOYL-PYRROLIDINE-MONOCARBOXYLIC HYDROGEN ACID AMIDS.
GB884576A (en) Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
AU225448B2 (en) r "Ferrous citrate complex, pharmaceutical preparations thereof and process for preparing the said complex
JPS51121524A (en) Agents for liver dysfunction
FR2019264A1 (en) Treatment of cyseinic lithiase using dithioss- - licylic acid
CA529114A (en) Therapeutic agent for the treatment of tuberculous diseases, especially tuberculosis of the lungs
AU230733B2 (en) Marked pharmaceutical tablet and method of marking the same